This edition: Mount Sinai Future You: Episode 3Tweet
Original tape date: July 4, 2018.
First aired: July 4, 2018.
Episode 3 features the story of a 22-year-old man from Idaho with a rare facial tumor called a lymphangioma. Following two dozen unsuccessful surgeries, he sought treatment from Gregory Levitin, MD, Director of Vascular Birthmarks and Malformations at New York Eye and Ear Infirmary of Mount Sinai, and one of the only surgeons in the country with expertise resecting these types of tumors. Our cameras followed the patient’s journey before and after surgery.
Other stories include a new technology that’s allowing breast cancer patients undergoing chemotherapy to keep their hair during treatment, a hybrid clinic-research lab called Lab 100 that is leveraging data from physical fitness and cognitive tests to help doctors obtain a more comprehensive health assessment of their patients, a link between strains of the herpes virus and Alzheimer’s disease, and a study of stem cells that are engineered to create new heart cells.
Kevin Costa, PhD Director of Cardiovascular Cell and Tissue Engineering, Mount Sinai Health System
Joel Dudley, PhD Director of the Institute for Next Generation Healthcare, Mount Sinai Health System
Sam Gandy, MD, PhD Associate Director of Mount Sinai Alzheimer’s Disease Research Center, Mount Sinai Health System
Paula Klein, MD Medical Director of Breast Cancer Clinical Trials, Mount Sinai Health System
Gregory Levitin, MD Director of Vascular Birthmarks and Malformations at New York Eye and Ear Infirmary of Mount Sinai, Mount Sinai Health System
Charles Shapiro, MD Director of Translational Breast Cancer Research and Director of Cancer Survivorship at the Tisch Cancer Institute, Mount Sinai Health System
David Stark, MD Director of Lab 100, Mount Sinai Health System